Global Radiotherapy Market and Forecast to 2030

GURUGRAM, India - Aug. 27, 2025 - PRLog -- The global radiotherapy market was valued at USD 7,100 Million in 2023, and is projected to reach USD 10,270 Million by 2030. Radiotherapy, also known as radiation therapy, is a medical treatment used to manage cancer and certain non-cancerous conditions. This non-invasive approach can be delivered externally through external beam radiotherapy or internally by placing radioactive materials close to or within the tumor, a method called brachytherapy. The primary goal of radiotherapy is to eradicate cancer cells while minimizing damage to surrounding tissues. According to Radiation Oncology Targeting Cancer, radiotherapy is responsible for 40% of all cures for cancer globally, as well as enhancing life quality for many more.

The radiotherapy industry is currently experiencing a transformation driven by technological advancements. Innovative tools and techniques—such as precision treatment delivery methods like intensity-modulated radiation therapy (IMRT), image-guided radiotherapy (IGRT), and stereotactic body radiation therapy (SBRT), which deliver highly targeted radiation doses to cancer cells—are significantly enhancing treatment outcomes. Additionally, the introduction of MRI LINAC systems allows for real-time imaging during therapy, and the integration of artificial intelligence in treatment planning and data analysis is further refining the accuracy and efficiency of radiotherapy. These technological advancements aim to enhance the performance of radiotherapy delivery systems and broaden their range of applications.

The expansion of the radiotherapy market is fueled by multiple factors, including the increasing prevalence of cancer, continuous technological innovations, greater awareness of the advantages of radiotherapy, rising healthcare spending, and the growing implementation of particle therapy in cancer treatment. According to GLOBOCAN 2022, approximately 19.98 million new cancer cases were reported in 2022. This number is projected to grow to 24.11 million by 2030 and reach 30.97 million by 2045. Radiotherapy continues to play a vital role in cancer care, with more than half of all cancer patients undergoing this treatment during their illness.

For more details, please visit: https://apeloconsulting.com/product/global-radiotherapy-m...